SPDR S&P Biotech ETF
742 hedge funds and large institutions have $8.2B invested in SPDR S&P Biotech ETF in 2022 Q4 according to their latest regulatory filings, with 122 funds opening new positions, 231 increasing their positions, 239 reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
742
Holders Change
+42
Holders Change %
+6%
% of All Funds
11.97%
Holding in Top 10
31
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-6.06%
% of All Funds
0.5%
New
122
Increased
231
Reduced
239
Closed
63
Calls
$1.66B
Puts
$1.31B
Net Calls
+$351M
Net Calls Change
+$262M
